TOMMorrow Study
Home Clinical Trials Prevention Trials
Prevention Trials: Bryan ADRC is currently engaged in large clinical trials to delay the onset of “Mild Cognitive Impairment” due to AD, the very early symptomatic stage of AD. The first of these studies is the TOMMorrow study.

Click here for more information about this exciting study.

Click here for more information on AAIC 2014.